Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Vertex’s CF Therapy Combination Trial Yields Promising Lung-Function Data

May 07 2012

Related Content

Vertex Gets Quick FDA Approval Of Kalydeco; Prices New CF Drug At $294,000 Per Year

Jan 31 2012

Early Success For <em>Kalydeco</em> Is Just The Beginning For Vertex’s CF Drug

Feb 06 2012

Related Companies

Vertex Pharmaceuticals Incorporated

Additional Topics

United States Clinical Trials Regulation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window